A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster
Clinical trial NCT06381843 · COMPLETED
Trial details
- NCT number
- NCT06381843
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2023-03-29
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.